FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037947522> ?p ?o ?g. }

• W2037947522 endingPage "369" @default.
• W2037947522 startingPage "364" @default.
• W2037947522 abstract "Approximately 50% of patients with estrogen receptor (ER)-positive breast cancer (BC) and 70%-80% of patients with ER-positive and progesterone receptor (PgR)-positive BC respond to hormonal therapy. Additional predictive markers are needed. A group of 287 patients with ER- and/or PgR-positive tumors was selected from 804 patients previously enrolled in a multicenter phase III trial. Bcl-2 expression was evaluated and correlated with response to adjuvant tamoxifen and survival. Estrogen receptor and PgR were determined by biochemical means and Bcl-2 by immunohistochemistry. With a median follow-up of 76 months (95 relapses and 60 deaths), of the 287 patients with, 187 (65%) had Bcl-2-positive tumors and 78 of these patients received tamoxifen. Of the 100 patients with Bcl-2-negative disease, 51 received tamoxifen and 49 regular follow-up. Using patients treated with tamoxifen as a reference, a univariate analysis of disease-free interval for patients who did not receive tamoxifen showed a hazard ratio (HR) of 1.42 (95% CI, 0.82-2.44; P = 0.21) for patients with Bcl-2-positive disease and a HR of 1.05 (95% CI, 0.55-1.99; P = 0.89) for patients with Bcl-2-negative disease (P = 0.48). After adjusting for number of positive lymph nodes, degree of receptor and PgR positivity, and type of surgery, the HRs were 1.54 (95% CI, 0.87-2.73; P = 0.14) for Bcl-2-positive disease and 1.05 (95% CI, 0.52-2.11; P = 0.88) for Bcl-2-negative disease. Despite its being a retrospective nonrandomized study with a relatively low number of patients, our results suggest that Bcl-2 deserves further evaluation as a predictive factor of sensitivity to tamoxifen." @default.
• W2037947522 created "2016-06-24" @default.
• W2037947522 creator A5011287454 @default.
• W2037947522 creator A5012187098 @default.
• W2037947522 creator A5025224681 @default.
• W2037947522 creator A5025554206 @default.
• W2037947522 creator A5029411458 @default.
• W2037947522 creator A5036821308 @default.
• W2037947522 creator A5057269336 @default.
• W2037947522 creator A5057557133 @default.
• W2037947522 creator A5073087918 @default.
• W2037947522 creator A5087380706 @default.
• W2037947522 date "2004-12-01" @default.
• W2037947522 modified "2023-09-23" @default.
• W2037947522 title "Potential Predictive Value of Bcl-2 for Response to Tamoxifen in the Adjuvant Setting of Node-Positive Breast Cancer" @default.
• W2037947522 cites W1492893697 @default.
• W2037947522 cites W1562190372 @default.
• W2037947522 cites W1598719623 @default.
• W2037947522 cites W1621124914 @default.
• W2037947522 cites W1870720170 @default.
• W2037947522 cites W1896390601 @default.
• W2037947522 cites W1904195737 @default.
• W2037947522 cites W1950270470 @default.
• W2037947522 cites W196157878 @default.
• W2037947522 cites W1993488798 @default.
• W2037947522 cites W1994039691 @default.
• W2037947522 cites W2003094395 @default.
• W2037947522 cites W2036822121 @default.
• W2037947522 cites W2039026077 @default.
• W2037947522 cites W2045086385 @default.
• W2037947522 cites W2056693620 @default.
• W2037947522 cites W2070862399 @default.
• W2037947522 cites W2097255042 @default.
• W2037947522 cites W2128985829 @default.
• W2037947522 cites W2131994307 @default.
• W2037947522 cites W2144322780 @default.
• W2037947522 cites W2222470382 @default.
• W2037947522 cites W2253846115 @default.
• W2037947522 doi "https://doi.org/10.3816/cbc.2004.n.043" @default.
• W2037947522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15585074" @default.
• W2037947522 hasPublicationYear "2004" @default.
• W2037947522 type Work @default.
• W2037947522 sameAs 2037947522 @default.
• W2037947522 citedByCount "12" @default.
• W2037947522 countsByYear W20379475222012 @default.
• W2037947522 countsByYear W20379475222014 @default.
• W2037947522 countsByYear W20379475222016 @default.
• W2037947522 crossrefType "journal-article" @default.
• W2037947522 hasAuthorship W2037947522A5011287454 @default.
• W2037947522 hasAuthorship W2037947522A5012187098 @default.
• W2037947522 hasAuthorship W2037947522A5025224681 @default.
• W2037947522 hasAuthorship W2037947522A5025554206 @default.
• W2037947522 hasAuthorship W2037947522A5029411458 @default.
• W2037947522 hasAuthorship W2037947522A5036821308 @default.
• W2037947522 hasAuthorship W2037947522A5057269336 @default.
• W2037947522 hasAuthorship W2037947522A5057557133 @default.
• W2037947522 hasAuthorship W2037947522A5073087918 @default.
• W2037947522 hasAuthorship W2037947522A5087380706 @default.
• W2037947522 hasConcept C121608353 @default.
• W2037947522 hasConcept C126322002 @default.
• W2037947522 hasConcept C143998085 @default.
• W2037947522 hasConcept C144301174 @default.
• W2037947522 hasConcept C207103383 @default.
• W2037947522 hasConcept C23589133 @default.
• W2037947522 hasConcept C2777176818 @default.
• W2037947522 hasConcept C2777982462 @default.
• W2037947522 hasConcept C29456083 @default.
• W2037947522 hasConcept C38180746 @default.
• W2037947522 hasConcept C44249647 @default.
• W2037947522 hasConcept C530470458 @default.
• W2037947522 hasConcept C71924100 @default.
• W2037947522 hasConcept C84606932 @default.
• W2037947522 hasConcept C98717036 @default.
• W2037947522 hasConceptScore W2037947522C121608353 @default.
• W2037947522 hasConceptScore W2037947522C126322002 @default.
• W2037947522 hasConceptScore W2037947522C143998085 @default.
• W2037947522 hasConceptScore W2037947522C144301174 @default.
• W2037947522 hasConceptScore W2037947522C207103383 @default.
• W2037947522 hasConceptScore W2037947522C23589133 @default.
• W2037947522 hasConceptScore W2037947522C2777176818 @default.
• W2037947522 hasConceptScore W2037947522C2777982462 @default.
• W2037947522 hasConceptScore W2037947522C29456083 @default.
• W2037947522 hasConceptScore W2037947522C38180746 @default.
• W2037947522 hasConceptScore W2037947522C44249647 @default.
• W2037947522 hasConceptScore W2037947522C530470458 @default.
• W2037947522 hasConceptScore W2037947522C71924100 @default.
• W2037947522 hasConceptScore W2037947522C84606932 @default.
• W2037947522 hasConceptScore W2037947522C98717036 @default.
• W2037947522 hasIssue "5" @default.
• W2037947522 hasLocation W20379475221 @default.
• W2037947522 hasLocation W20379475222 @default.
• W2037947522 hasOpenAccess W2037947522 @default.
• W2037947522 hasPrimaryLocation W20379475221 @default.
• W2037947522 hasRelatedWork W1997479244 @default.
• W2037947522 hasRelatedWork W2000536166 @default.
• W2037947522 hasRelatedWork W2034831048 @default.
• W2037947522 hasRelatedWork W2057553101 @default.
• W2037947522 hasRelatedWork W2066639616 @default.

• next